BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hasebe M, Yoshikawa K, Ohashi S, Toubaru S, Kawaguchi K, Sato J, Mizoe J, Tsujii H. A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET. Mol Imaging Biol 2010;12:554-62. [PMID: 20369300 DOI: 10.1007/s11307-010-0318-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kilian K, Pękal A, Szkutnik W, Pyrzyńska K. A fast method for the determination of residual solvents in 18FDG and 11C-methionine samples. Microchemical Journal 2014;115:95-9. [DOI: 10.1016/j.microc.2014.02.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Quartuccio N, Caobelli F, Di Mauro F, Cammaroto G. Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art. Nuclear Medicine Communications 2016;37:891-8. [DOI: 10.1097/mnm.0000000000000530] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Challapalli A, Aboagye EO. Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring. Front Oncol 2016;6:44. [PMID: 26973812 DOI: 10.3389/fonc.2016.00044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
4 Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T, Hamada Y. Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma. Int J Oral Maxillofac Surg 2017;46:1220-8. [PMID: 28535963 DOI: 10.1016/j.ijom.2017.04.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Tomura N, Mizuno Y, Saginoya T. PET/CT findings for tumors in the base of the skull: comparison of 18 F-FDG with 11 C-methionine. Acta Radiol 2016;57:325-32. [PMID: 25795702 DOI: 10.1177/0284185115575342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
6 Hoigebazar L, Jeong JM, Hong MK, Kim YJ, Lee JY, Shetty D, Lee YS, Lee DS, Chung JK, Lee MC. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers. Bioorg Med Chem 2011;19:2176-81. [PMID: 21419635 DOI: 10.1016/j.bmc.2011.02.041] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
7 Isohashi K, Shimosegawa E, Kato H, Kanai Y, Naka S, Fujino K, Watabe H, Hatazawa J. Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV. EJNMMI Res 2013;3:27. [PMID: 23587060 DOI: 10.1186/2191-219X-3-27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A, Ronchi S, Fiore MR, Paganelli C, Buizza G, Ciocca M, Baroni G, Preda L, Orlandi E. Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review. Br J Radiol 2021;94:20210524. [PMID: 34520670 DOI: 10.1259/bjr.20210524] [Reference Citation Analysis]
9 Toubaru S, Yoshikawa K, Ohashi S, Tanimoto K, Hasegawa A, Kawaguchi K, Saga T, Kamada T. Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck. Radiat Oncol 2013;8:143. [PMID: 23758795 DOI: 10.1186/1748-717X-8-143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]